Top Banner
ULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double- beam spectrophotometers with sample solutions prepared as specified in the individual monographs. The horizontal axis indicates the wavelength (nm) and the vertical axis indi- cates the absorbance.
27

ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

Mar 26, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

ULTRAVIOLET-VISIBLEREFERENCE SPECTRA

The ultraviolet-visible reference spectra presented here were obtained by the use of double-

beam spectrophotometers with sample solutions prepared as specified in the individual

monographs. The horizontal axis indicates the wavelength (nm) and the vertical axis indi-

cates the absorbance.

Page 2: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22252225JP XVII Ultraviolet-visible Reference Spectra

Acebutolol Hydrochloride

Acemetacin

Acetohexamide 1

Page 3: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22262226 JP XVIIUltraviolet-visible Reference Spectra

Acetohexamide 2

Aciclovir

Aclarubicin Hydrochloride

Page 4: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22272227JP XVII Ultraviolet-visible Reference Spectra

Acrinol Hydrate

Actinomycin D

Adrenaline

Page 5: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22282228 JP XVIIUltraviolet-visible Reference Spectra

Afloqualone

Alimemazine Tartrate

Allopurinol

Page 6: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22292229JP XVII Ultraviolet-visible Reference Spectra

Alminoprofen

Alprazolam

Alprenolol Hydrochloride

Page 7: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22302230 JP XVIIUltraviolet-visible Reference Spectra

Alprostadil

Alprostadil Alfadex

Ambenonium Chloride

Page 8: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22312231JP XVII Ultraviolet-visible Reference Spectra

Amiodarone Hydrochloride

Amitriptyline Hydrochloride

Amlexanox

Page 9: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22322232 JP XVIIUltraviolet-visible Reference Spectra

Amlodipine Besilate

Amosulalol Hydrochloride

Amoxapine

Page 10: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22332233JP XVII Ultraviolet-visible Reference Spectra

Amphotericin B

Ampiroxicam

Aprindine Hydrochloride

Page 11: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22342234 JP XVIIUltraviolet-visible Reference Spectra

Argatroban Hydrate

Arotinolol Hydrochloride

Aspoxicillin Hydrate

Page 12: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22352235JP XVII Ultraviolet-visible Reference Spectra

Atenolol

Atorvastatin Calcium Hydrate

Azathioprine

Page 13: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22362236 JP XVIIUltraviolet-visible Reference Spectra

Azelastine Hydrochloride

Azelnidipine

Aztreonam

Page 14: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22372237JP XVII Ultraviolet-visible Reference Spectra

Bacampicillin Hydrochloride

Baclofen

Bamethan Sulfate

Page 15: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22382238 JP XVIIUltraviolet-visible Reference Spectra

Benidipine Hydrochloride

Benserazide Hydrochloride

Benzalkonium Chloride

Page 16: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22392239JP XVII Ultraviolet-visible Reference Spectra

Benzbromarone

Benzethonium Chloride

Benzylpenicillin Benzathine Hydrate

Page 17: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22402240 JP XVIIUltraviolet-visible Reference Spectra

Benzylpenicillin Potassium

Bepotastine Besilate

Beraprost Sodium

Page 18: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22412241JP XVII Ultraviolet-visible Reference Spectra

Berberine Chloride Hydrate

Berberine Tannate

Betahistine Mesilate

Page 19: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22422242 JP XVIIUltraviolet-visible Reference Spectra

Betamethasone

Betamethasone Dipropionate

Betamipron

Page 20: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22432243JP XVII Ultraviolet-visible Reference Spectra

Betaxolol Hydrochloride

Bezafibrate

Bifonazole

Page 21: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22442244 JP XVIIUltraviolet-visible Reference Spectra

Biperiden Hydrochloride

Bisacodyl

Bisoprolol Fumarate

Page 22: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22452245JP XVII Ultraviolet-visible Reference Spectra

Bleomycin Hydrochloride

Bleomycin Sulfate

Bromazepam

Page 23: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22462246 JP XVIIUltraviolet-visible Reference Spectra

Bromhexine Hydrochloride

Bromocriptine Mesilate

Brotizolam

Page 24: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22472247JP XVII Ultraviolet-visible Reference Spectra

Bucumolol Hydrochloride

Bufetolol Hydrochloride

Buformin Hydrochloride

Page 25: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22482248 JP XVIIUltraviolet-visible Reference Spectra

Bumetanide

Bupivacaine Hydrochloride Hydrate

Bupranolol Hydrochloride

Page 26: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22492249JP XVII Ultraviolet-visible Reference Spectra

Buprenorphine Hydrochloride

Butenafine Hydrochloride

Butropium Bromide 1

Page 27: ULTRAVIOLET-VISIBLE REFERENCE SPECTRAULTRAVIOLET-VISIBLE REFERENCE SPECTRA The ultraviolet-visible reference spectra presented here were obtained by the use of double-beam spectrophotometers

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)

22502250 JP XVIIUltraviolet-visible Reference Spectra

Butropium Bromide 2

Cadralazine

Calcitonin Salmon